JU
Jupiter Neurosciences, Inc.
JUNS · NASDAQ
$2.93 -6.39% (-$0.20)
1M -40.51%
Market Cap $1.42M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 21.95x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 54.62%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 88.34%
Net margin 14,220.10%
Op. margin 15,166.70%
Quality
0 /100
Poor ROIC 709.40%
ROA 247.39%
Asset turnover 0.02x
Debt
7 /100
High Current ratio 0.66x
Int. coverage -262.75x
Debt/Equity N/A
Stability
4 /100
Unstable Beta 1.79x
EPS volatility 126.84%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na JUNS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christer Rosen
Employees
5
Headquarters
Jupiter
Nadcházející události
02 PRO
Earnings
Upcoming earnings report